These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3092393)

  • 21. [Serum myoglobin levels and creatine phosphokinase activity in patients with myocardial infarct, unstable angina pectoris and spontaneous angina pectoris].
    Halawa B
    Wiad Lek; 1985 Sep; 38(18):1265-72. PubMed ID: 4090501
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy and safety of the factor VIII/von Willebrand factor concentrate, haemate-P/humate-P: ristocetin cofactor unit dosing in patients with von Willebrand disease.
    Lillicrap D; Poon MC; Walker I; Xie F; Schwartz BA;
    Thromb Haemost; 2002 Feb; 87(2):224-30. PubMed ID: 11858481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New treatments of von Willebrand disease: plasma derived von Willebrand factor concentrates.
    Menache D; Aronson DL
    Thromb Haemost; 1997 Jul; 78(1):566-70. PubMed ID: 9198217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in plasma von Willebrand factor-cleaving protease (ADAMTS13) levels in patients with unstable angina.
    Fuchigami S; Kaikita K; Soejima K; Matsukawa M; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Nakagaki T; Sugiyama S; Ogawa H
    Thromb Res; 2008; 122(5):618-23. PubMed ID: 18295305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endothelin and big endothelin in coronary heart disease and acute coronary syndromes].
    Borries M; Heins M; Fischer Y; Stiegler H; Schoebel FC; Reinauer H; Strauer BE; Leschke M
    Z Kardiol; 1996 Oct; 85(10):761-7. PubMed ID: 9036701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3.
    Michiels JJ; Gadisseur A; van der Planken M; Schroyens W; van de Velden A; Berneman Z
    Semin Thromb Hemost; 2006 Sep; 32(6):636-45. PubMed ID: 16977574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
    Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease.
    Lubetsky A; Schulman S; Varon D; Martinowitz U; Kenet G; Gitel S; Inbal A
    Thromb Haemost; 1999 Feb; 81(2):229-33. PubMed ID: 10063997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma concentration of von Willebrand factor in acute myocardial infarction.
    Sakai H; Goto S; Kim JY; Aoki N; Abe S; Ichikawa N; Yoshida M; Nagaoka Y; Handa S
    Thromb Haemost; 2000 Aug; 84(2):204-9. PubMed ID: 10959690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative in vitro evaluation of six von Willebrand factor concentrates.
    Lethagen S; Carlson M; Hillarp A
    Haemophilia; 2004 May; 10(3):243-9. PubMed ID: 15086321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
    Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
    Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seminal Factor VIII and von Willebrand Factor: a possible role of the conventional clotting system in human semen?
    Lwaleed BA; Greenfield R; Royle E; Birch B; Cooper AJ
    Int J Androl; 2005 Feb; 28(1):31-8. PubMed ID: 15679619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
    Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AJvW-2, an anti-vWF monoclonal antibody, inhibits enhanced platelet aggregation induced by high shear stress in platelet-rich plasma from patients with acute coronary syndromes.
    Eto K; Isshiki T; Yamamoto H; Takeshita S; Ochiai M; Yokoyama N; Yoshimoto R; Ikeda Y; Sato T
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):877-82. PubMed ID: 10195912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in factor VIII proteins after cardiopulmonary bypass in man suggest endothelial damage.
    Jones DK; Luddington R; Higenbottam TW; Scott J; Cavarocchi N; Reardon D; Calvin J; Wallwork J
    Thromb Haemost; 1988 Oct; 60(2):199-204. PubMed ID: 2975406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Platelet functions in patients with acute myocardial infarction].
    Jin L; Yan XW; Xu SH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Oct; 17(5):275-8, 317. PubMed ID: 2636123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating Serum Levels of Pentraxin-3, von Willebrand Factor and C-X-C Motif Chemokine Ligand 13 as Inflammatory Markers of Unstable Angina Pectoris.
    Raygan F; Mohammadi H; Etminan A; Sehat M; Nikoueinejad H
    Iran J Allergy Asthma Immunol; 2019 Apr; 18(2):200-208. PubMed ID: 31066256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.